Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NESP vs rHuEPO for Anemia in Pediatric CRI/ESRD
NCT00527137Phase 3Completed
- Sponsor
- Amgen
- Start
- Aug 2000
- Primary completion
- Nov 2004
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Aug 2000; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00527137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527137.